Influx rate constant of 18F-FDG increases in metastatic lymph nodes of non-small cell lung cancer patients

被引:29
|
作者
Yang, Min [1 ,2 ,3 ]
Lin, Zhong [4 ]
Xu, Zeqing [5 ]
Li, Dan [1 ,2 ,3 ]
Lv, Weize [4 ]
Yang, Shuai [4 ]
Liu, Ye [6 ]
Cao, Ying [7 ]
Cao, Qingdong [8 ]
Jin, Hongjun [1 ,2 ,3 ]
机构
[1] Sun Yat Sen Univ, Guangdong Prov Key Lab Biomed Imaging, Affiliated Hosp 5, Zhuhai 519000, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Guangdong Prov Engn Res Ctr Mol Imaging, Affiliated Hosp 5, Zhuhai 519000, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 5, Ctr Mol Imaging, Zhuhai 519000, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 5, Ctr Oncol, Zhuhai 519000, Guangdong, Peoples R China
[5] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Nucl Med, Zhuhai 519000, Guangdong, Peoples R China
[6] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Pathol, Zhuhai 519000, Guangdong, Peoples R China
[7] Peoples Liberat Army Gen Hosp, Med Ctr 1, Beijing 100853, Peoples R China
[8] SunYat sen Univ, Affiliated Hosp 5, Dept Cardiothorac Surg, Zhuhai 519000, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
Non-small cell lung cancer; F-18-FDG; Dynamic PET; CT; Patlak; Metastatic lymph nodes; POSITRON-EMISSION-TOMOGRAPHY; NONINVASIVE QUANTIFICATION; METABOLIC-RATE; BODY-WEIGHT; FDG UPTAKE; PET; REPRODUCIBILITY; EXPRESSION; THERAPY; GLUT-1;
D O I
10.1007/s00259-020-04682-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose Primary tumor (PT) and metastatic lymph node (MLN) status have a great influence on diagnosis and treatment of lung cancer. Our main purpose was to investigate the imaging characteristics of PT or MLN by applying the F-18-FDG PET dynamic modeling approach for non-small cell lung cancer (NSCLC). Methods Dynamic F-18-FDG PET scans were performed for 76 lung cancer patients, and 62 NSCLC cases were finally included in this study: 37 with newly diagnosed early and locally advanced lung cancer without distant metastases (group M0) and 25 metastatic lung cancer (group M1). Patlak graphic analysis (K-i calculation) based on the dynamic modeling and SUV analysis from conventional static data were performed. Results For PT, both K-i(PT) (0.050 +/- 0.005 vs 0.026 +/- 0.004 min(-1), p < 0.001) and SUVPT (8.41 +/- 0.64 vs 5.23 +/- 0.73, p < 0.01) showed significant higher values in group M1 than M0. For MLN, K-i(MLN) showed significant higher values in M1 than M0 (0.033 +/- 0.005 vs 0.016 +/- 0.003 min(-1), p < 0.01), while no significant differences were found for SUVMLN between M0 and M1 (4.22 +/- 0.49 vs 5.57 +/- 0.59, p > 0.05). Both SUV (PT) and K-i(PT) showed significant high values in squamous cell carcinoma than adenocarcinoma, but neither SUVPT nor K-i(PT) showed significant differences between EGFR mutants versus wild types. The overall Spearman analysis for SUV and K-i from different groups showed variable correlation (r = 0.46-0.94). Conclusion The dynamic modeling for MLN (K-i(MLN)) showed more sensitive than the static analysis (SUV) to detect metastatic lymph nodes in NSCLC, although both methods were sensitive for PT. This methodology of non-invasive imaging may become an important tool to evaluate MLN and PT status for patients who cannot undergo histological examination.
引用
收藏
页码:1198 / 1208
页数:11
相关论文
共 50 条
  • [31] Dual-Time-Point F-18 FDG PET/CT for Evaluation of Intrathoracic Lymph Nodes in Patients With Non-Small Cell Lung Cancer
    Shinya, Takayoshi
    Rai, Kammei
    Okumura, Yoshihiro
    Fujiwara, Keiichi
    Matsuo, Kiyoshi
    Yonei, Toshiro
    Sato, Toshio
    Watanabe, Kazuhiko
    Kawai, Haruyuki
    Sato, Shuhei
    Kanazawa, Susumu
    CLINICAL NUCLEAR MEDICINE, 2009, 34 (04) : 216 - 221
  • [32] Prognostic Value of Metabolic Parameters of Metastatic Lymph Nodes on 18F-FDG PET/CT in Patients With Limited-stage Small-cell Lung Cancer With Lymph Node Involvement
    Jin, Feng
    Qu, Bo
    Fu, Zheng
    Zhang, Yan
    Han, Anqin
    Kong, Li
    Yu, Jinming
    CLINICAL LUNG CANCER, 2018, 19 (01) : E101 - E108
  • [33] Comparison of Timor Uptake Heterogeneity Characterization Between Static and Parametric 18F-FDG PET Images in Non-Small Cell Lung Cancer
    Tixier, Florent
    Vriens, Dennis
    Cheze-Le Rest, Catherine
    Hatt, Mathieu
    Disselhorst, Jonathan A.
    Oyen, Wim J. G.
    de Geus-Oei, Lioe-Fee
    Visser, Eric P.
    Visvikis, Dimitris
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (07) : 1033 - 1039
  • [34] Repeat 18F-FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non-small cell lung cancer
    Eschmann, S. M.
    Friedel, G.
    Paulsen, F.
    Reimold, M.
    Hehr, T.
    Budach, W.
    Dittmann, H.
    Langen, H. -J.
    Bares, R.
    LUNG CANCER, 2007, 55 (02) : 165 - 171
  • [35] Prognostic Value of 18F-FDG Uptake on Positron Emission Tomography in Patients with Pathologic Stage I Non-small Cell Lung Cancer
    Um, Sang-Won
    Kim, Hojoong
    Koh, Won-Jung
    Suh, Gee Young
    Chung, Man Pyo
    Kwon, O. Jung
    Choi, Joon Young
    Han, Joungho
    Lee, Kyung Soo
    Kim, Jhingook
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (11) : 1331 - 1336
  • [36] Comparison of 18F-FDG PET/CT and MDCT for staging/restaging of non-small cell lung cancer
    Sobic-Saranovic, D.
    Petrusic, I.
    Artiko, V.
    Pavlovic, S.
    Subotic, D.
    Saranovic, D.
    Nagorni-Obradovic, L.
    Petrovic, N.
    Todorovic-Tirnanic, M.
    Odalovic, S.
    Grozdic-Milojevic, I.
    Stoiljkovic, M.
    Obradovic, V.
    NEOPLASMA, 2015, 62 (02) : 295 - 301
  • [37] Prediction of pathological complete response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer using 18F-FDG PET radiomics features of primary tumour and lymph nodes
    Liu, Xingbiao
    Ji, Zhilin
    Zhang, Libo
    Li, Linlin
    Xu, Wengui
    Su, Qian
    BMC CANCER, 2025, 25 (01)
  • [38] Time course of early response to chemotherapy in non-small cell lung cancer patients with 18F-FDG PET/CT
    Nahmias, Claude
    Hanna, Wahid T.
    Wahl, Lindi M.
    Long, Misty J.
    Hubner, Karl F.
    Townsend, David W.
    JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (05) : 744 - 751
  • [39] Is standardised 18F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?
    S. M. Eschmann
    G. Friedel
    F. Paulsen
    M. Reimold
    T. Hehr
    W. Budach
    J. Scheiderbauer
    H. J. Machulla
    H. Dittmann
    R. Vonthein
    R. Bares
    European Journal of Nuclear Medicine and Molecular Imaging, 2006, 33 : 263 - 269
  • [40] Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer
    Liao, Shengri
    Penney, Bill C.
    Wroblewski, Kristen
    Zhang, Hao
    Simon, Cassie A.
    Kampalath, Rony
    Shih, Ming-Chi
    Shimada, Naoko
    Chen, Sheng
    Salgia, Ravi
    Appelbaum, Daniel E.
    Suzuki, Kenji
    Chen, Chin-Tu
    Pu, Yonglin
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (01) : 27 - 38